VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Biomarkers, Tumor
Blotting, Western
Boronic Acids
Bortezomib
Cell Proliferation
Drug Resistance, Neoplasm
Drug Synergism
Enzyme-Linked Immunosorbent Assay
Flow Cytometry
Gene Expression Profiling
Humans
Imidazoles
Insulin-Like Growth Factor I
Mice
Mice, SCID
Multiple Myeloma
Oligonucleotide Array Sequence Analysis
Pyrazines
Receptor, IGF Type 1
Survival Rate
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
DONNA M WEBER
LUHUA WANG
PEI LIN
SHEEBA KOSHY THOMAS
VEERABHADRAN BALADANDAYUTHAPANI
ROBERT ORLOWSKI
RICHARD ERIC DAVIS